Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CITE observational study of eltrombopag in chronic immune thrombocytopenia
ChiCTR1900021755Phase 4Not yet recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of eltrombopag in immune thrombocytopenia (ITP), sponsored by Shanghai Sixth People's Hospital. Primary endpoints: Treatment duration and adherence and Efficacy (hematological and clinical). Planned start Oct 2018; status: not yet recruiting.
02
Drugs
eltrombopag
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on ChiCTR1900021755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021755.